Litigation Finance 2.0 and Patent Settlements: How Third-Party Funding Is Reshaping Big Tech’s Defense in the Western District of Texas

1. WDTX as the Staging Ground

The Western District of Texas has become the most strategically significant venue for funded patent enforcement in the United States. In 2025, the WDTX accounted for 11.5% of all patent filings nationally and 17.5% of all NPE (non-practicing entity) cases, making it the second most active district for NPE-led litigation. Only the Eastern District of Texas surpasses it, capturing 27.7% of overall filings and a commanding 44.2% of NPE cases. Together, Texas courts now handle more than 60% of all NPE patent cases filed in the United States.

This concentration is not accidental. NPEs were responsible for 90.3% of high-tech patent litigation in 2025, and their filing strategies are shaped by venue-specific procedural advantages. Judge Alan Albright, who moved to the Austin division in 2025, maintains an aggressive trial timeline of approximately 24 months from filing to trial—a pace that makes the WDTX uniquely attractive to litigation funders who need predictable time-to-resolution for their portfolio models.

Source: Unified Patents, Patent Dispute Report: 2025 in Review

2. Litigation Finance 2.0 Mechanics

The litigation finance industry has undergone a structural transformation. What began as single-case funding—a funder backing one plaintiff in one lawsuit—has evolved into a sophisticated capital deployment model built on portfolio-driven probability. Total capital committed to patent litigation finance reached $672 million in 2023 and continues to grow, driven by institutional investors seeking uncorrelated returns and the maturing operational infrastructure that now supports funded litigation at scale.

Three structural innovations define the 2.0 era. First, the Management Services Organization (MSO) model provides the operational backbone for law firms pursuing funded patent cases, handling finance, human resources, and client intake while the firm retains control over legal strategy. Second, Alternative Business Structures (ABS) permit direct non-lawyer ownership in law firms in certain jurisdictions, enabling capital providers to take equity stakes in the firms themselves rather than merely funding individual cases. Third, the portfolio effect—investing in a basket of 10 to 20 patent assets and expecting power-law returns—transforms litigation from a high-risk, binary gamble into a diversified strategy where a single outsized verdict can underwrite the losses across the rest of the portfolio.

3. Erosion of Attrition Warfare

For decades, the primary defense strategy against patent assertions was attrition warfare: outspend the plaintiff, prolong discovery, file serial motions, and wait for the claimant’s resources to run out. This approach was devastatingly effective against under-capitalized NPEs and solo inventors—and it remains embedded in the institutional memory of most corporate litigation departments. But TPLF 2.0 has fundamentally undermined the economics of attrition.

Litigation funders provide what amounts to an off-balance-sheet war chestfor plaintiffs, shifting litigation risk from the patent holder to the third-party capital provider. A plaintiff backed by a well-capitalized fund can absorb years of discovery costs, expert fees, and trial preparation expenses without flinching. In the WDTX, this dynamic is amplified by Judge Albright’s Standing Order governing patent cases, which imposes focused discovery on a “short fuse”—limiting the defendant’s ability to weaponize procedural delay.

The financial consequences are visible in the data. The median verdict among the largest patent damage awards has risen to $98 million, up from $49.7 million in 2019. Six of the ten largest damage awards in 2025 were issued by Texas juries, ranging from $78.5 million to $445.5 million. Decision-tree analysis tools—such as Eperoto—are replacing intuition-based settlement decisions, allowing funders to price litigation risk with actuarial precision. The result: settlement premiums are at historic highs, because defendants can no longer credibly threaten to bleed a funded plaintiff dry.

4. PTAB — Weakening of the Administrative Safety Valve

Since the America Invents Act created inter partes review (IPR) in 2012, the PTAB has served as the technology sector’s primary administrative safety valve against weak patents. By petitioning the PTAB, defendants could challenge patent validity in a proceeding that was faster, cheaper, and statistically more favorable than district court litigation. That safety valve is now closing.

The IPR institution rate against NPE-asserted patents dropped from 64.6% in Q1 2025 to just 33.6% by Q4 2025—a collapse that has left defendants with dramatically fewer options for invalidating patents before trial. Multiple factors are driving this decline. Fintiv-style discretionary denials remain a persistent obstacle: the PTAB routinely declines to institute review when a WDTX trial date is already set within a comparable timeframe, on the theory that parallel proceedings would be duplicative. Director John Squires has imposed more centralized oversight with increasingly stringent requirements for institution. Overall PTAB challenge filings have hit a 10-year low.

In response, defendants have pivoted to ex parte reexamination, which saw a 66% increasein filings during 2025. But reexaminations lack the procedural power to stay district court proceedings—a limitation that actually benefits litigation funders, who can continue pursuing trial on their preferred timeline while the reexamination grinds through the USPTO. The convergence of declining IPR institution rates and accelerated WDTX trial schedules has created an environment where funded plaintiffs face fewer administrative obstacles than at any point in the past decade.

5. Technical Theaters: AI, Semiconductors, Infrastructure

The most consequential funded patent campaigns are now targeting the infrastructure layer of the artificial intelligence stack—interconnect technologies, data processing units (DPUs), memory hierarchies, and semiconductor packaging. With data center capital expenditure projected to reach $370 billion annualized by 2026, the economic stakes for both plaintiffs and defendants are enormous.

Litigation targeting core AI infrastructure creates existential risks for financing structures on both sides. For defendants, an adverse verdict on a fundamental interconnect patent could trigger default cascades in credit facilities and raise securities fraud disclosure obligations. For funders, concentrated exposure to a single technical domain introduces correlation risk that undermines the portfolio diversification thesis.

The damages theories in these cases revolve around the tension between two apportionment frameworks. Plaintiffs invoke the Entire Market Value Rule (EMVR), arguing that the patented feature is the “basis for consumer demand” for the entire AI server or accelerator card. Defendants counter with the Smallest Salable Patent-Practicing Unit (SSPPU), seeking to confine the royalty base to the specific component that embodies the patented invention. WDTX juries, known for their pro-patentee tendencies, have historically been more receptive to EMVR arguments—a factor that further incentivizes funders to steer cases into this venue.

6. Legislative Counter-Responses

The rapid growth of litigation finance has triggered a wave of legislative activity aimed at increasing transparency and limiting the influence of third-party funders in patent cases. Three bills are now moving through Congress, each targeting a different facet of the funding ecosystem.

H.R. 7015, the Protecting Third Party Litigation Funding From Abuse Act, introduced on January 12, 2026, by Representative Darrell Issa, is the most comprehensive proposal. It would require mandatory disclosure of all litigation funding arrangements in federal civil cases, including the identity of the funder, the terms of the agreement, and any control or decision-making authority the funder holds over litigation strategy. H.R. 1109, the Litigation Transparency Act of 2025, takes a narrower approach focused on disclosure at the outset of litigation. A third bill, the Protecting Our Courts from Foreign Manipulation Act, frames the issue through a national security lens, targeting funding arrangements involving foreign sovereign wealth funds and state-controlled entities.

Industry groups including the National Association of Mutual Insurance Companies (NAMIC) and the American Property Casualty Insurance Association (APCIA) have endorsed mandatory disclosure. The bills collectively aim to achieve three strategic objectives for defendants: identify hostile foreign funders whose involvement may raise national security concerns, enable defendants to prolong litigation to exhaust funder capital through attrition, and provide a basis for arguing that funded cases are “investor-driven” rather than meritorious assertions of patent rights.

The WDTX currently relies on judicial discretion for disclosure—there are no mandatory rules requiring parties to reveal funding arrangements. If any of these bills become law, the procedural landscape in the Western District could shift dramatically, particularly for portfolio funders whose business model depends on anonymity.

7. Defensive Strategies in the Age of TPLF 2.0

Technology companies are adapting their defense postures in response to the funded litigation environment. SEC risk disclosures from major technology firms now routinely cite “litigation abuse” and TPLF as material risk factors, reflecting the degree to which funded patent assertions have become a recognized threat to corporate earnings.

The most sophisticated defensive responses involve alternative risk transfer mechanisms borrowed from the insurance industry. Multi-year casualty insurance programs and structured risk insurance products allow defendants to cap their downside exposure to patent verdicts. Two emerging instruments deserve particular attention: WiP (Work in Progress) insurance and ATE (After-the-Event) insurance, which can cover litigation costs retroactively if a case takes an adverse turn. On the defendant side, Judgment Preservation Insurance (JPI)protects against the risk that a favorable trial verdict is reversed on appeal—a growing concern given the Federal Circuit’s increasing scrutiny of damages evidence.

8. Economic Implications & Future Outlook

The macroeconomic consequences of funded patent litigation extend well beyond the courtroom. According to a 2026 CALA analysis, TPLF may reduce household purchasing power by more than $600 per year through higher insurance premiums and consumer prices as companies pass through litigation costs. Capital hoarding for litigation war chests diverts resources from research and development—a particular concern for mid-cap technology companies that lack the balance sheets of their larger peers.

Recent settlements illustrate the scale of capital now flowing through funded patent assertions. Samsung’s $150 million settlement in a funded patent case was widely viewed as public vindication of the litigation finance model, demonstrating that portfolio-backed plaintiffs can extract nine-figure outcomes without ever reaching trial. This result has accelerated the entry of new capital into the space: the global litigation funding market reached $19.3 billion in 2025 and is projected to grow to $53.2 billion by 2035.

Looking ahead, three trends will shape the next phase. First, appellate monetization—funding post-verdict appeals to capture upside from favorable district court judgments—is surging in 2026, extending the duration and complexity of funded litigation. Second, the WDTX will remain the primary testing ground for novel funding structures, given its procedural advantages and historically pro-patentee jury pools. Third, legislative disclosure requirements, if enacted, could introduce meaningful friction into the funding process by exposing portfolio strategies to defendants and the public—though the political trajectory of these bills remains uncertain.

What is clear is that litigation finance has moved beyond an emerging trend into a permanent feature of the patent enforcement landscape. Companies that fail to adapt their defensive strategies to account for funded adversaries are not merely accepting higher litigation costs—they are ceding strategic advantage to plaintiffs whose capital backing has fundamentally altered the leverage dynamics of patent settlements.

Sources

Selected primary or official reference materials used for this guide.

• Patent Dispute Report: 2025 in Review — Unified Patents
• 2026 Litigation Funding Trends — GLS Capital
• H.R. 7015 — Protecting Third Party Litigation Funding From Abuse Act
• Judge Albright Standing Order — W.D. Texas
• The New Realities of Funded Patent Litigation — Holland & Knight
• Impact of TPLF on U.S. Business Activity — CALA (2026)